The relationship between low Trop2 expression and elevated ErbB3 activation was also observed in primary HNSCC tumors, and importantly, we demonstrate that Trop2 loss confers sensitivity to ErbB3 antibodies in tumor xenografts derived from HNSCC cells. This evidence concerns the gene ERBB3 and head and neck squamous cell carcinoma.